THE RESULT OF TREATMENT FOR CIRRHOTIC PATIENTS WITH GASTROINTESTINAL BLEEDING DUE TO GASTRIC VARICOSE VEINS AT BACH MAI HOSPITAL

Anh Tuấn Nguyễn1,, Hữu Việt Anh Nguyễn2
1 Bach Mai Hospital
2 Hanoi Medical University

Main Article Content

Abstract

Objective: Describe the result of treating for cirrhotic patients with gastrointestinal bleeding due to gastric varicose veins  at Bach Mai Hospital. Method: Prospective, Descriptive study to treatment for 101 cases of cirrhosis  with gastrointestinal bleeding due to gastric varicose veins  at Bach Mai Hospital from 2021-2022. Results: In the study, 80 patients (79.2%) received red blood cells transfusion with a volume of 1108.38 ± 645.88 ml, and 20 patients (19.8%) received a platelet transfusion with a volume of 347.0 ± 141.31 ml and 31 patients (30.7%) were transfused fresh frozen plasm with the amount of 667.74 ± 456.94 ml. 100% of patients had diagnostic endoscopy, of which 47 patients (46.5%) had endoscopic variceal ligation and 41 patients (40.5%) had endoscopic injection sclerotherapy. 96 patients (95.1%) got successful hemostasis. The number of patients requiring endotracheal intubation was 10, correspconding to 9.9% of patients. The rate of very severe illness and death was 17/101 patients (16.8%). Conclusion: Infusion of blood products according to indications and timely interventional endoscopy are the main and effective treatments for cirrhotic patients with gastrointestinal bleeding due to gastric varicose veins and accord with circumstance in emergency department.

Article Details

References

1. De Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5(3):645-663. doi: 10.1016/s1089-3261(05)70186-0
2. Hwang JH, Shergill AK, Acosta RD, et al. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc. 2014; 80(2):221-227. doi:10.1016/j.gie.2013.07.023
3. De Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743-752. doi:10.1016/j.jhep.2015.05.022
4. Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015; 64(11):1680-1704. doi:10.1136/gutjnl-2015-309262
5. Lee EW, Shahrouki P, Alanis L, Ding P, Kee ST. Management Options for Gastric Variceal Hemorrhage. JAMA Surg. 2019;154(6):540-548. doi:10.1001/jamasurg.2019.0407
6. Jairath V, Rehal S, Logan R, et al. Acute variceal haemorrhage in the United Kingdom: Patient characteristics, management and outcomes in a nationwide audit. Dig Liver Dis. 2014;46(5):419-426. doi:10.1016/j.dld.2013.12.010
7. Wang J, Tian XG, Li Y, et al. Comparison of modified percutaneous transhepatic variceal embolization and endoscopic cyanoacrylate injection for gastric variceal rebleeding. World J Gastroenterol WJG. 2013;19(5):706-714. doi:10.3748/wjg.v19.i5.706
8. Kim JW, Baik SK, Kim KH, et al. [Effect of endoscopic sclerotherapy using N-butyl-2-cyanoacrylate in patients with gastric variceal bleeding]. Korean J Hepatol. 2006;12(3):394-403.